Printer Friendly
The Free Library
14,736,044 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

AAIPharma Acquires Rentschler Clinical Development Team through its German Subsidiary.


WILMINGTON, N.C. -- AAIPharma Inc. (PINK SHEET:AAIIQ) announced today that through its German subsidiary, it has entered into a strategic agreement with Rentschler Biotechnologie GmbH & Co. KG, a European-based full service contract manufacturer of drugs containing recombinant proteins Since human recombinants have replaced the animal version in human therapeutics, the prefix of "rh" for "human recombinant" appears less and less in the literature Human recombinants that replaced animal or harvested from human types
. Under the terms of the agreement, AAIPharma has acquired the clinical research team of Rentschler's Clinical Development Operation in this field and agreed to carry out certain existing clinical services contracts with Rentschler's customers on a subcontract sub·con·tract  
n.
A contract that assigns some of the obligations of a prior contract to another party.

intr. & tr.v. sub·con·tract·ed, sub·con·tract·ing, sub·con·tracts
 basis. In addition, Rentschler and AAIPharma through its German subsidiary agreed to cooperate in providing the whole range of their technological and clinical expertise to customers of the pharmaceutical and biotechnology industries.

This agreement facilitates the development and management of relationships with biotech bi·o·tech  
n. Informal
Biotechnology.


biotech
Noun

short for biotechnology

Noun 1.
 customers and provides AAIPharma's clinical development operations with additional experience in the planning, performance and evaluation of clinical studies involving biotechnology drugs.

Dr. Ludo ludo
Noun

Brit & Austral a simple board game in which players move counters forward by throwing dice [Latin: I play]

Noun 1.
 Reynders, President and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board.  of AAIPharma, remarked, "The addition of this biotech expertise to our clinical development operation is an important step in strengthening our organization in Europe. It enhances our overall business plan for the biotechnology sector, and Rentschler's primary and secondary manufacturing capability complements our U.S. sterile manufacturing capability enabling the Company to offer customers both U.S. Food and Drug Administration and European regulatory agencies regulatory agency

Independent government commission charged by the legislature with setting and enforcing standards for specific industries in the private sector. The concept was invented by the U.S.
 compliant manufacturing services."

About AAIPharma

AAIPharma Inc. is a global provider of product development and support services support services Psychology Non-health care-related ancillary services–eg, transportation, financial aid, support groups, homemaker services, respite services, and other services  to the pharmaceutical, biotechnology, and medical device industries. From a single test through a range of integrated service offerings, we create value to an industry in search of productivity and innovation. For more information on the Company, please visit AAIPharma's website at www.aaipharma.com.
COPYRIGHT 2005 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2005, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Geographic Code:1USA
Date:Oct 18, 2005
Words:274
Previous Article:Dollar General Former Chairman, CEO Will Retire as Advisor to the Board.
Next Article:St. Jude Medical Commences Tender Offer for Advanced Neuromodulation Systems.
Topics:



Related Articles
How a 'new' Sterling Casting burst through a dark cloud of bankruptcy. (includes related article on how the company overcame an equipment...
Hamilton Foundry Plans to File for Chapter 11.(Brief Article)(Statistical Data Included)
Epicyte Partners with aaiPharma to Develop Industry's First Topical Mononclonal Antibody.
FOR THE RECORD.(Vitals)
Copy writers.(Investments & Finance)(Brief Article)
Applied Science & Technology Inc.(Paul Rentschler appointed)(Brief Article)
Two Germans in the Civil War: The Diary of John Daeuble and the Letters of Gottfried Rentschler, 6th Kentucky Volunteer Infantry.(Book Review)
aaiPharma Announces Strategic Hires.
AAIPharma Expands Clinical and Non-Clinical Operations with New Strategic Hires.
AAIPharma Establishes AAIOncology Business Unit and Expands Global Clinical Development Operations through Acquisition of Cvitkovic & Associes...

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles